Shi-Ming Lin

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

Masao Omata, Laurentius A. Lesmana, Ryosuke Tateishi et al. · Hepatology International · 2010 · 1K citations · Full text

A Changing Paradigm for the Treatment of Intermediate-Stage Hepatocellular Carcinoma: Asia-Pacific Primary Liver Cancer Expert Consensus Statements

Masatoshi Kudo, Kwang‐Hyub Han, Sheng-Long Ye et al. · Liver Cancer · 2020 · 295 citations · Full text

Surgical Oncology, Intermediate-stage Hcc, Pathology +21

Phase III HEAT Study Adding Lyso-Thermosensitive Liposomal Doxorubicin to Radiofrequency Ablation in Patients with Unresectable Hepatocellular Carcinoma Lesions

Won Young Tak, Shi-Ming Lin, Yijun Wang et al. · Clinical Cancer Research · 2017 · 158 citations

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

Hepatology, Transarterial Chemoembolisation, Medicine +8

Management consensus guideline for hepatocellular carcinoma: 2020 update on surveillance, diagnosis, and systemic treatment by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan

Yu‐Yun Shao, Shen-Yung Wang, Shi‐Ming Lin et al. · Journal of the Formosan Medical Association · 2020 · 113 citations · Full text

Oncologic Imaging, Gastroenterology, Pathology +20